InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[Analystnueve]

I agree (mostly) with what each of you are saying, but in my opinion the problem is with our government because they notoriously move slowly. Frank Reynolds can do little to change that. What he can do is assemble a dream team and a winning plan. As of this year, I believe this has taken place. And with the HDE pathway, I think finally the company can move forward. I'm fine with the road shows because NVIV is very under the radar and could use more publicity. At $2.30 on 5/2/12 in my opinion NVIV is trading at least 50 cents lower than where is should and could trade right now.